Funder
Cancer Prevention and Research Institute of Texas
V Foundation for Cancer Research
Susan G. Komen
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Max and Minnie Tomerlin Voelcker Fund
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. Dai, X. et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am. J. Cancer Res. 5, 2929–2943 (2015).
2. Fu, J. & Jeffrey, S. S. Transcriptomic signatures in breast cancer. Mol. Biosyst. 3, 466–472 (2007).
3. Murphy, C. G. & Dickler, M. N. Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies. Endocr. Relat. Cancer 23, R337–R352 (2016).
4. Musgrove, E. A. & Sutherland, R. L. Biological determinants of endocrine resistance in breast cancer. Nat. Rev. Cancer 9, 631–643 (2009).
5. Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934–947 (2013).
Cited by
95 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献